ZAHRA SHAFAEE, M.D.
Radiology at White Plains Rd, Yonkers, NY

License number
New York 222908
Category
Radiology
Type
Surgical Oncology
Address
Address
685 White Plains Rd, Yonkers, NY 10709
Phone
(914) 787-4107
(914) 779-0344 (Fax)

Personal information

See more information about ZAHRA SHAFAEE at radaris.com
Name
Address
Phone
Zahra Shafaee
600 W 246Th St APT 315, Bronx, NY 10471
(718) 548-0233
Zahra Shafaee, age 56
7 Meadow Rd, Scarsdale, NY 10583
Zahra Shafaee, age 56
4901 Henry Hudson Pkwy W, Bronx, NY 10471
(718) 548-6632
Zahra Shafaee, age 78
501 Riverdale Ave, Yonkers, NY 10705
Zahra Shafaee
600 246Th St, Bronx, NY 10471
(718) 548-0233

Organization information

See more information about ZAHRA SHAFAEE at bizstanding.com

Zahra Shafaee MD

955 Yonkers Ave STE 12, Yonkers, NY 10704

Categories:
Physicians & Surgeons
Phone:
(914) 237-7031 (Phone)

Professional information

Zahra Shafaee Photo 1

Zahra Shafaee, Eastchester NY

Specialties:
Surgery, Surgical Oncology
Work:
Lawrence Medical Associates
685 White Plns, Eastchester, NY 10709 Woodhull Medical/Mental Hlth Center
760 Broadway, Brooklyn, NY 11206
Education:
Mashhad University Of Medical Sciences (1993)


Zahra Shafaee Photo 2

Combination Therapy Of Hedgehog Inhibitors, Radiation And Chemotherapeutic Agents

US Patent:
2011004, Feb 24, 2011
Filed:
Oct 27, 2010
Appl. No.:
12/913459
Inventors:
Ralph R. Weichselbaum - Chicago IL, US
Zahra Shafaee - Bronxville NY, US
Wei Du - Chicago IL, US
Assignee:
The University of Chicago - Chicago IL
International Classification:
A61K 31/337, A61P 35/00, C12N 5/02
US Classification:
514449, 435375
Abstract:
The present invention relates to therapeutic combinations and methods of inhibiting the proliferation of cancerous cells, the abnormal growth of cells, and tumor cell growth using the combination of a hedgehog inhibitor with chemotherapy and/or radiation therapy. The present invention also relates to methods of enhancing the antiproliferative effect of chemotherapy and/or radiation therapy in a mammalian cancer patient undergoing either chemotherapy or radiation or a combination of radiation and chemotherapy by co-administering a therapeutically amount of a hedgehog inhibitor, concurrently or sequentially, with the chemotherapy and/or radiation therapy.